Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

This study has been terminated.
(Terminated due to very slow enrollment)
Information provided by (Responsible Party):
Genta Incorporated Identifier:
First received: October 10, 2007
Last updated: November 4, 2011
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)